Predictors for progression in immunoglobulin A nephropathy with significant proteinuria

Nephrology

Volumn 15, Issue 2, 2010, Pages 236-241

  Hwang, Hyeon Seok ^a   Kim, Byung Soo ^a   Shin, Young Shin ^a   Yoon, Hye Eun ^a   Song, Joon Chang ^a   Choi, Bum Soon ^a   Park, Cheol Whee ^a   Yang, Chul Woo ^a   Kim, Yong Soo ^a   Bang, Byung Kee ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Immunoglobulin A nephropathy; Progression; Proteinuria; Treatment response

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PREDNISOLONE;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEINURIA; SURVIVAL RATE; SURVIVAL TIME; TREATMENT RESPONSE;

ADULT; BIOPSY; BLOOD PRESSURE; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS, IGA; HUMANS; KAPLAN-MEIERS ESTIMATE; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROTEINURIA; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77749302194     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2009.01196.x     Document Type: Article

References (27)

1. D'amico G. The most commonest glomerulonephritis in the world: IgA nephropathy. Q. J. Med. 1987 245 : 709 727.
2. Maisonneuve P, Agodoa L, Gellert R et al. Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: Results from an international comparative study. Am. J. Kidney Dis. 2000 35 : 157 165.
3. Koyama A, Igarashi M, Kobayashi M. Natural history and risk factors for immunoglobulin A nephropathy in Japan. Research Group on Progressive Renal Diseases. Am. J. Kidney Dis. 1997 29 : 526 532.
4. Berthoux FC, Mohey H, Afiani A. Natural history of primary IgA nephropathy. Semin. Nephrol. 2008 28 : 4 9.
5. D'amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin. Nephrol. 2004 24 : 179 196.
6. Lv JC, Zhang H, Zhou Y, Li GT, Zou WZ, Wang HY. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: A long-term follow up of 204 cases in China. Nephrology. 2008 13 : 242 246.
7. Alamartine E, Sabatier JC, Guerin C et al. Prognostic factors in mesangial IgA glomerulonephritis: An extensive study with univariate and multivariate analyses. Am. J. Kidney Dis. 1991 18 : 12 9.
8. D'amico G. Natural history of idiopathic IgA nephropathy: Role of clinical and histological prognostic factors. Am. J. Kidney Dis. 2000 35 : 157 165.
9. Bartosik LP, Lajoie G, Sugar L, Cattran DC. Predicting progression in IgA nephropathy. Am. J. Kidney Dis. 2001 38 : 728 735.
10. Woo KT, Lau YK, Wong KS, Chiang GSC. ACEI/ATRA therapy decreases proteinuria by improving glomerular permselectivity in IgA nephritis. Kidney Int. 2000 58 : 2485 2491.
11. Praga M, Gutiérrez E, González E, Morales E, Hernández E. Treatment of IgA nephropathy with ACE inhibitors: A randomized and controlled trial. J. Am. Soc. Nephrol. 2003 14 : 1578 1583.
12. Dillon JJ. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for IgA nephropathy. Semin. Nephrol. 2004 24 : 218 224.
13. Ballardie FW, Cowley RD. Prognostic indices and therapy in IgA nephropathy: Toward a solution. Kidney Int. 2008 73 : 249 251.
14. Barratt J, Feehally J. IgA Nephropathy. J. Am. Soc. Nephrol. 2005 16 : 2088 2097.
15. Locatelli F, Pozzi C, Andrulli S. IgA nephritis: ACE inhibitors, steroids, both or neither? Nephrol. Dial. Transplant. 2006 21 : 3357 3361.
16. Floege J, Eitner F. Immune modulating therapy for IgA nephropathy: Rationale and evidence. Semin. Nephrol. 2008 28 : 38 47.
17. Eknoyan G, Levin N. NKFK/DOQI clinical practice guidelines Update 2000. Foreword. Am. J. Kidney Dis. 2001 37 : S5 6.
18. Reich H, Troyanov S, Scholey JW, Cattran DC. Remission of proteinuria improves prognosis in IgA nephropathy. J. Am. Soc. Nephrol. 2007 18 : 3177 3183.
19. Levey AS, Greene T, Kusek JW, Beck GJ. A simplified equation to predict glomerular filtration rate from serum creatinine. J. Am. Soc. Nephrol. 2000 11 : A0828.
20. Sinniah R. IgA mesangial nephropathy: Berger's disease. Am J Nephrol. 1985 5 : 73 83.
21. Donadio JV, Bergstralh EJ, Grande JP, Rademcher DM. Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy. Nephrol. Dial. Transplant. 2002 17 : 1197 1203.
22. Barratt J, Feehally J. Treatment of IgA nephropathy. Kidney Int. 2006 69 : 1934 1938.
23. Ballardie FW. Quantitative appraisal of treatment options for IgA nephropathy. J. Am. Soc. Nephrol. 2007 18 : 2806 2809.
24. Szeto CC, Lai FM, To KF et al. The natural history of immunoglobulin a nephropathy among patients with hematuria and minimal proteinuria. Am. J. Med. 2001 110 : 434 437.
25. Harada K, Akai Y, Yamaguchi Y et al. Prediction of corticosteroid responsiveness based on fibroblast-specific protein 1 (FSP1) in patients with IgA nephropathy. Nephrol. Dial. Transplant. 2008 23 : 3152 3159.
26. Du Y, Wu QQ, Liang H et al. Association of angiotensin I-converting enzyme gene insertion/deletion polymorphism and IgA nephropathy: A meta-analysis. Am. J. Nephrol. 2006 26 : 511 518.
27. Yamamoto R, Nagasawa Y, Shoji T et al. A candidate gene approach to genetic prognostic factors of IgA nephropathy - a result of polymorphism research to distinguish genetic factors contributing to progression of IgA nephropathy (PREDICT-IgAN). Nephrol. Dial. Transplant. 2009, Epub ahead of print. [Cited 16 Sep 2009.] Available from URL: http://ndt.oxfordjournals.org/ cgi/reprint/gfp210v1